Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin

M. Reck, N. Thatcher, E.F. Smit, P. Lorigan, E. Szutowicz-Zielinska, A.M. Liepa, K.B. Winfree, P. Peterson, S.C. Guba, MA Socinski

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)276-281
JournalLung Cancer
Issue number3
Publication statusPublished - 2012

Cite this